Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Beyond hemostasis: Factor VIII deficiency impacts hematopoietic stem cells development in zebrafish

Blood (2025) 146 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2025-4933

Published: 2025

Journal Articles

Activated factor IX Ρadua delivered via adeno-associated virus enhances therapeutic efficacy in hemophilia B

Li Liu, Junjiang Sun, Timothy Nichols, Qiling Geng, Congling Xiao, Emma Tang, Zhenwei Song, Pedro Albelda de la Haza, Chengwen Li

Blood (2025) 146 (Supplement 1): 4311.

https://doi.org/10.1182/blood-2025-4311

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Venetoclax plus mitoxantrone hydrochloride liposome and Azacitidine As first-line treatment for adults with Acute Myeloid Leukemia

Zhuo Wan, Dian Lou, Jingyu Hu, Xiaotong Gao, Huaipeng Guo, Naicen Zhou, Meiying Qi, Panpan Li, Dan Fan, Cong Liu, Guohui Li, Huaiyu Wang, Xiaoning Wang, Li Liu, Weiwei Qi

Blood (2025) 146 (Supplement 1): 3456.

https://doi.org/10.1182/blood-2025-3456

Published: 2025

Journal Articles

Hetrombopag for patients with persistent primary immune thrombocytopenia: A post-hoc analysis of a multicenter, randomized phase Ⅲ Trial

Blood (2025) 146 (Supplement 1): 4812.

https://doi.org/10.1182/blood-2025-4812

Published: 2025

Journal Articles

Trial in Progress: The Phase 3, Randomized, Double-Blind, Placebo-Controlled QuANTUM-Wild Study of Quizartinib in Combination With Chemotherapy and as Single-Agent Maintenance in Newly Diagnosed, FLT3 -ITD-Negative Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 1504.3.

https://doi.org/10.1182/blood-2024-205101

Published: 2024

Journal Articles

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Tingting Zhang, Li Liu, Xiaohui Zheng, Biao Shen, Ming Gong, Xin Liu, Gang Li, Ying Zhang, Wenbin Cao, Chen Liang, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2828.

https://doi.org/10.1182/blood-2024-209406

Published: 2024

Journal Articles

Development of Allogeneic Dual-Targeting CD19/BCMA CAR-T Cell Therapeutics Using ALL-in-One Site-Specific Integration Technology for Autoimmune Diseases

Zhu Li, Yaling Zheng, Huanyu Wang, Chao Zhang, Li Liu, Lulu Lv, Li Zhou

Blood (2024) 144 (Supplement 1): 4785.

https://doi.org/10.1182/blood-2024-199874

Published: 2024

Journal Articles

Development of a Novel Allogeneic Super -Γδ T Cell Therapy for Acute Myeloid Leukemia and Multiple Tumors

Hanlu Wang, Li Liu, Chao Zhang, Junxiao Gao, Lulu Lv, Li Zhou

Blood (2024) 144 (Supplement 1): 2058.

https://doi.org/10.1182/blood-2024-201322

Published: 2024

Journal Articles

Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3 -ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial

Blood (2024) 144 (Supplement 1): 848.

https://doi.org/10.1182/blood-2024-203303

Published: 2024

Journal Articles

Quantum-First: Effects of Quizartinib (Q) on RFS, OS, CIR, and MRD in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3 -ITD+) Acute Myeloid Leukemia (AML) Who Received Continuation (CONT) Therapy (tx)

Mark J. Levis, Harry Erba, Pau Montesinos, Elzbieta Patkowska, Jorge E. Cortes, Herve Dombret, Alexander E. Perl, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Li Liu, Yasser M. Mostafa Kamel, Karima Imadalou, Abderrahmane Laadem, Mikkael A. Sekeres, Kristy Burns

Blood (2024) 144 (Supplement 1): 2890.

https://doi.org/10.1182/blood-2024-207305

Published: 2024

Journal Articles

HLTF Regulates Erythroid Differentiation through Transcription Factors and Chromatin Landscape Modulation

Han Gong, Bin Hu, Wenwen Xu, Pan Wang, Maohua Li, Ling Nie, Huifang Zhang, Li Liu, Yue Sheng, Long Liang, Xu Han, Mohandas Narla, Jing Liu

Blood (2024) 144 (Supplement 1): 3845.

https://doi.org/10.1182/blood-2024-207540

Published: 2024

Journal Articles

A Phase 2 Dose-Finding Trial of MY008211A in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria and Signs of Active Hemolysis

Fengkui Zhang, Li Zhang, Miao Chen, Hongyan Tong, Xiaoni Li, Wei Wang, Li Liu, Geoffrey Ross

Blood (2024) 144 (Supplement 1): 2701.

https://doi.org/10.1182/blood-2024-210973

Published: 2024

Journal Articles

Gemtuzumab Ozogamicin in Favorable and Intermediate Risk Acute Myeloid Leukemia: A Single-Center Experience

Jia Li Liu, Nushin Sadeghi, Owen Luo, Jonathan How, John M. Storring, Gizelle Popradi

Blood (2024) 144 (Supplement 1): 6029.

https://doi.org/10.1182/blood-2024-198536

Published: 2024

Journal Articles

Quantum-First: Deep-Dive Analysis of FMS-like Tyrosine Kinase 3-Internal Tandem Duplication (FLT3 -ITD) Detection Methods Utilized for Enrollment and Longitudinal MRD Detection in Newly Diagnosed (nd) Patients (pts) with FLT3 -ITD-Positive (FLT3 -ITD+) Acute Myeloid Leukemia (AML)

Jaime E. Connolly Rohrbach, Edward Waldron, Li Liu, Shawn Rivera, Sridevi Kayyur Subramanya, Violet Abraham, Alexander E. Perl, Mark J. Levis

Blood (2024) 144 (Supplement 1): 4278.

https://doi.org/10.1182/blood-2024-201727

Published: 2024

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Mitoxantrone Hydrochloride Liposome Containing Regimen in Patients with Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective, Real-World Study

JUN MA, Tiejun Gong, Donglu Zhao, Xiaoyu Zhu, Xiaojing Yan, Junjie Ma, Yun Cai, HongXiang Wang, Mei Hong, Li Liu, Qiang Song, Xin Wang

Blood (2023) 142 (Supplement 1): 5897.

https://doi.org/10.1182/blood-2023-187864

Published: 2023

Journal Articles

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Runzhi Ma, Sisi Zhen, Li Liu, Jieru Wang, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7094.

https://doi.org/10.1182/blood-2023-190923

Published: 2023

Journal Articles

Quantum-First: Safety By Treatment Phase and By Age in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD) Positive Acute Myeloid Leukemia (AML)

Harry P. Erba, Herve Dombret, Alexander Perl, Tsvetomir Mitov, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Youngsook Choi, Mark J. Levis, Richard F Schlenk

Blood (2023) 142 (Supplement 1): 972.

https://doi.org/10.1182/blood-2023-186206

Published: 2023

Journal Articles

Kinetics of Complete Remission (CR) and CR Duration and Its Impact on Overall Survival (OS) and Event-Free Survival (EFS) in Quantum-First

Pau Montesinos, Alexander Perl, Mikkael A. Sekeres, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Richard F Schlenk, Harry P. Erba, Hervé Dombret

Blood (2023) 142 (Supplement 1): 4254.

https://doi.org/10.1182/blood-2023-187286

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Beyond hemostasis: Factor VIII deficiency impacts hematopoietic stem cells development in zebrafish

Activated factor IX Ρadua delivered via adeno-associated virus enhances therapeutic efficacy in hemophilia B

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Venetoclax plus mitoxantrone hydrochloride liposome and Azacitidine As first-line treatment for adults with Acute Myeloid Leukemia

Hetrombopag for patients with persistent primary immune thrombocytopenia: A post-hoc analysis of a multicenter, randomized phase Ⅲ Trial

Trial in Progress: The Phase 3, Randomized, Double-Blind, Placebo-Controlled QuANTUM-Wild Study of Quizartinib in Combination With Chemotherapy and as Single-Agent Maintenance in Newly Diagnosed, FLT3 -ITD-Negative Acute Myeloid Leukemia

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Development of Allogeneic Dual-Targeting CD19/BCMA CAR-T Cell Therapeutics Using ALL-in-One Site-Specific Integration Technology for Autoimmune Diseases

Development of a Novel Allogeneic Super -Γδ T Cell Therapy for Acute Myeloid Leukemia and Multiple Tumors

Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3 -ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial

Quantum-First: Effects of Quizartinib (Q) on RFS, OS, CIR, and MRD in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3 -ITD+) Acute Myeloid Leukemia (AML) Who Received Continuation (CONT) Therapy (tx)

HLTF Regulates Erythroid Differentiation through Transcription Factors and Chromatin Landscape Modulation

A Phase 2 Dose-Finding Trial of MY008211A in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria and Signs of Active Hemolysis

Gemtuzumab Ozogamicin in Favorable and Intermediate Risk Acute Myeloid Leukemia: A Single-Center Experience

Quantum-First: Deep-Dive Analysis of FMS-like Tyrosine Kinase 3-Internal Tandem Duplication (FLT3 -ITD) Detection Methods Utilized for Enrollment and Longitudinal MRD Detection in Newly Diagnosed (nd) Patients (pts) with FLT3 -ITD-Positive (FLT3 -ITD+) Acute Myeloid Leukemia (AML)

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Mitoxantrone Hydrochloride Liposome Containing Regimen in Patients with Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective, Real-World Study

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Quantum-First: Safety By Treatment Phase and By Age in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD) Positive Acute Myeloid Leukemia (AML)

Kinetics of Complete Remission (CR) and CR Duration and Its Impact on Overall Survival (OS) and Event-Free Survival (EFS) in Quantum-First

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only